Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PHARMACYTE BIOTECH, INC. (PMCB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PHARMACYTE BIOTECH, INC. (PMCB), most recent 12 months reported: revenue $0, net loss $16.15M. Latest balance sheet on file: liquid cash $30.51M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): OUTLOOK THERAPEUTICS, INC. · PALISADE BIO, INC. · PASSAGE BIO, INC. · Vaxcyte, Inc. · REPLIMUNE GROUP, INC. · Revolution Medicines, Inc. · SAB BIOTHERAPEUTICS, INC. · Sana Biotechnology, Inc.

Stock screener

Watchlist